Pertussis before and after the introduction of acellular pertussis vaccines in Finland

Vaccine

Volumn 27, Issue 40, 2009, Pages 5443-5449

  Elomaa, Annika ^a,b   He, Qiushui ^a   Minh, Nhu Nguyen Tran ^a   Mertsola, Jussi ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bordetella pertussis; Pertussis vaccine; Whooping cough

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; DRUG DOSE REGIMEN; FINLAND; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; LABORATORY DIAGNOSIS; PERTUSSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER;

ADOLESCENT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FINLAND; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; PERTUSSIS VACCINE; VACCINES, ACELLULAR; WHOOPING COUGH; YOUNG ADULT;

EID: 68349160702     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.010     Document Type: Article

References (31)

1. Sabella C. Pertussis: old foe, persistent problem. Cleve Clin J Med 72 7 (2005) 601-608
2. WHO. Pertussis (whooping cough). WHO-recommended standards for surveillance of selected vaccine-preventable diseases (2003) p. 28-30
3. Leino T., Koskenniemi E., Saranpää P.-R., Strömberg N., and Kilpi T. Rokotuskattavuus edelleen huippuluokkaa. Suom Laakaril 62 (2007) 739-743
4. He Q., Mertsola J., Himanen J.P., Ruuskanen O., and Viljanen M.K. Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis. Eur J Clin Microbiol Infect Dis 12 (1993) 690-695
5. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., Hallander H., et al. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol 43 (2005) 3681-3687
6. Heikkinen E., Xing D., Ölander R.-M., Hytönen J., Viljanen M., Mertsola J., et al. Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 8 (2008) 162
7. Mäkinen J., Mertsola J., Viljanen M.K., Arvilommi H., and He Q. Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol 40 (2002) 2213-2216
8. Mäkinen J., Viljanen M.K., Mertsola J., Arvilommi H., and He Q. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. Emerg Infect Dis 7 (2001) 952-958
9. Advani A., Donnelly D., and Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol 42 (2004) 2890-2897
10. Mooi F.R., Hallander H., Wirsing von Konig C.H., Hoet B., and Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19 (2000) 174-181
11. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., He Q., et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 25 (2007) 918-926
12. Jefferson T., Rudin M., and DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 21 (2003) 2003-2014
13. Simondon F., Preziosi M.P., Yam A., Kane C.T., Chabirand L., Iteman I., et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 15 (1997) 1606-1612
14. Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet 30 (1988) 955-960
15. Tindberg Y., Blennow M., and Granstrom M. A ten year follow-up after immunization with a two component acellular pertussis vaccine. Pediatr Infect Dis J 18 (1999) 361-365
16. Carlsson R, Gustafsson L, Hallander H. Eight year report: pertussis surveillance in Sweden. Solna, Sweden: Smittskyddsinstitutet; 2006 July.
17. Hallander H.O. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand J Infect Dis 31 (1999) 281-286
18. Korppi M., and Hiltunen J. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection. Pediatr Infect Dis J 26 (2007) 316-318
19. Caro V., Njamkepo E., Van Amersfoorth S.C., Mooi F.R., Advani A., Hallander H.O., et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microb Infect 7 (2005) 976-982
20. Hallander H., Advani A., Riffelmann M., von Konig C.H.W., Caro V., Guiso N., et al. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 45 (2007) 3257-3262
21. van Amersfoorth S.C., Schouls L.M., van der Heide H.G., Advani A., Hallander H.O., Bondeson K., et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43 (2005) 2837-2843
22. Heininger U., Frei R., Cherry J.D., and Stehr K. Comparison of pulsed field gel electrophoresis patterns of Bordetella pertussis isolates from unvaccinated children with severe or mild pertussis. Pediatr Infect Dis J 23 (2004) 211-217
23. Brinig M.M., Cummings C.A., Sanden G.N., Stefanelli P., Lawrence A., and Relman D.A. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188 (2006) 2375-2382
24. Caro V., Hot D., Guigon G., Hubans C., Arrive M., Soubigou G., et al. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microb Infect 8 (2006) 2228-2235
25. Heikkinen E., Kallonen T., Saarinen L., Sara R., King A.J., Mooi F.R., et al. Comparative Genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS ONE 2 (2007) e904
26. Forsyth K.D., Wirsing von Konig C.H., Tan T., Caro J., and Plotkin S. Prevention of pertussis: recommendations derived from the second global pertussis initiative roundtable meeting. Vaccine 25 (2007) 2634-2642
27. Van Rie A., and Hethcote H.W. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 22 (2004) 3154-3165
28. Mooi F.R., and de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 7 (2007) 614-624
29. Halasa N.B., O'Shea A., Shi J.R., LaFleur B.J., and Edwards K.M. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 153 (2008) 327-332
30. Wood N., and McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 9 (2008) 201-212
31. Mielcarek N., Debrie A.S., Raze D., Bertout J., Rouanet C., Younes A.B., et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2 (2006) e65